manusyriac
☆    

India,
2018-09-20 11:45
(1835 d 17:05 ago)

Posting: # 19293
Views: 1,936
 

 Usage of different lots of RLDs in multistage adaptive studies [Regulatives / Guidelines]

Hi All,

Can we use different lots of RLDS in multistage studies as the study design requires more than 2 years of shelf-life for RLDs. If it is possible please help me to find any relevant regulatory guidance for the same.

Thank you.
ElMaestro
★★★

Denmark,
2018-09-20 14:19
(1835 d 14:30 ago)

@ manusyriac
Posting: # 19294
Views: 1,668
 

 Usage of different lots of RLDs in multistage adaptive studies

Hi manusyriac,

❝ Can we use different lots of RLDS in multistage studies as the study design requires more than 2 years of shelf-life for RLDs. If it is possible please help me to find any relevant regulatory guidance for the same.


Without being absolutely sure I think this would be ok with most EU authorities for the reasons you state. Less convinced about how HC or FDA or PMDA would see it.
Note that in your case batch and stage will have the same meaning for the product(s) in question.

Pass or fail!
ElMaestro
manusyriac
☆    

India,
2018-09-20 15:05
(1835 d 13:45 ago)

(edited by Ohlbe on 2018-09-20 23:16)
@ ElMaestro
Posting: # 19295
Views: 1,654
 

 Usage of different lots of RLDs in multistage adaptive studies

Thanks for your quick response.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
UA Flag
Activity
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
13 visitors (0 registered, 13 guests [including 8 identified bots]).
Forum time: 04:50 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5